A neonate born to a mother with Graves disease may develop transient hyperthyroidism. Skuza et al evaluated these infants and identified endpoints when antithyroid antibodies could be discontinued. The authors are from the University of Medicine and Dentistry-New Jersey, Children's Hospital of New Jersey in Newark and Endocrine Sciences in California.
